Delivery Order SPE2DB22D3301-SPE2DB24FY4BH
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,979,969 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The $6,268.05 delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp as the sole prime contractor. This IDC serves as the primary vehicle for Amerisourcebergen Drug Corp to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $5,617.86 contract is for the provision of 4,563,955,495 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
- This is a $39,598.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The order is for the supply of 4,565,235,791 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract has a period of performance through July 25, 2024 and was awarded on July 24, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division to supply 4,564,435,268 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The $6,213.76 firm fixed-price contract has an ultimate completion date of April 30, 2024 and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4,567,202,673 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a ceiling value of $5,044.30. The contract has a firm fixed price and a completion date of February 10, 2025. This order is placed under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,451.67 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,956,103 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccines. The contract has a ceiling value of $3,421.00 and a performance period through March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds as the sole prime...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,670,234 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a ceiling value of $2,879.76. The contract has a Firm Fixed Price pricing type and is a Delivery Order. The contract has an ultimate completion date of March 24, 2025. The contract does not have a set-aside...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of 4,564,145,812 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine, with a ceiling value of $4,158.25 and a performance period through April 3, 2024. This delivery order is part of a larger indefinite delivery contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is for the provision of 4,564,931,979 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a ceiling value of $13,070.08. It is a firm fixed-price contract with a period of performance ending on June 18, 2024. Amerisourcebergen holds a larger...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY4BHDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,183,176 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract has a ceiling value of $37,452.40 and a period of performance through April 8, 2024. This delivery order appears to be part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 with a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.5k | 4/5/24 |